Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00979316 · ClinicalTrials.gov registry record · Phase 1
Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 62
- Enrollment target
NCT00979316: Completed Phase 1 study, sponsored by Bristol-Myers Squibb.
NCT00979316 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 62 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00979316, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of BMS-708163 on the QTc interval (QT interval corrected for heart rate).
Interventions
- DRUG Placebo
- DRUG Moxifloxacin
- DRUG BMS-708163
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-02 |
| Phase | Phase 1 |
What the finished NCT00979316 record still lists
NCT00979316 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00979316 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00979316 about?
NCT00979316 is a clinical study titled "Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects". The purpose of this study is to determine the effect of BMS-708163 on the QTc interval (QT interval corrected for heart rate).
What is the current status of trial NCT00979316?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 62 participants. The study started on 2009-09. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00979316?
The interventions under investigation include: Placebo (DRUG), Moxifloxacin (DRUG), BMS-708163 (DRUG).
Who is sponsoring clinical trial NCT00979316?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00979316's enrollment target sits among peer trials
62 824th of 2000 higher than 1,173 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia